Trial intelligence / Profile preview

Trimetrexate With Leucovorin Calcium Rescue Versus Trimethoprim / Sulfamethoxazole for Moderately Severe Pneumocystis Carinii Pneumonia in Patients With AIDS

NCT00001013Phase 3Completed

Sponsor
National Institute of Allergy and Infectious Diseases
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of trimetrexate glucuronate in Pneumocystis pneumonia (PCP), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.

02

Drugs

trimetrexate glucuronate
03

Conditions

Pneumocystis pneumonia (PCP)

Beyond the preview

Go deeper on NCT00001013.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00001013.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call